Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas J Gintjee"'
Publikováno v:
Journal of Fungi, Vol 6, Iss 1, p 28 (2020)
Invasive fungal infections are associated with significant morbidity and mortality, and their management is restricted to a variety of agents from five established classes of antifungal medication. In practice, existing antifungal agents are often co
Externí odkaz:
https://doaj.org/article/569b724537c54ed1a8ac4666f8b2a590
Autor:
Kara L. Lynch, Eddie Garcia, Thomas J Gintjee, Daniel Repplinger, Adina Badea, Kai Li, Robert Goodnough
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1759-1761
Introduction Capecitabine is an orally bioavailable prodrug of the chemotherapeutic agent, fluorouracil. Fluorouracil is converted to several active metabolites that induce a cytotoxic effect. Capecitabine toxicity can be life-threatening with a dela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc12d025c23817505d7e5504dcb6492f
https://doi.org/10.1177/1078155220906266
https://doi.org/10.1177/1078155220906266
Autor:
Amanda M. Roy, Thomas J Gintjee, Conan MacDougall, Jason C. Gallagher, Toni A Campanella, Monica A. Donnelley
Publikováno v:
Open Forum Infectious Diseases
Background Valganciclovir (VGC), an oral prodrug of ganciclovir (GCV), is 60% bioavailable. Manufacturer-recommended doses are adjusted for creatinine clearance (CrCl), but not weight (wt), while GCV doses are adjusted for CrCl and wt. Patients expos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251fa837afc78a9a3e63aea22a9db6e1
http://europepmc.org/articles/PMC7777869
http://europepmc.org/articles/PMC7777869
Autor:
Thomas J Gintjee, Alex Odermatt, Minh-Vu Hoang Nguyen, George Richard Thompson, Brian Y Young, Matthew R Davis
Publikováno v:
Open Forum Infectious Diseases
Background Posaconazole-induced pseudohyperaldosteronism (PIPH) has been associated with elevated posaconazole serum concentrations. Clinicians are faced with the difficult task of managing patients with PIPH while not compromising the efficacy of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90df255d5d2a3d6214d416324b120382
https://doi.org/10.1093/ofid/ofaa439.942
https://doi.org/10.1093/ofid/ofaa439.942